Similar Papers

Paper Title
Journal
Date
Author
Serum Mass-Spectrometry Test in First Line Advanced Nsclc Patients Treated with Standard Chemotherapy Regimens
F Grossi ... F Biello
Annals of Oncology | VOL. 25
F Grossi, et. al.F Grossi ... F Biello
01 Sep 2014
P1.04-78 Efficacy of Checkpoint Inhibitors in Combination with Chemotherapy for First-Line Treatment of Advanced Non-Squamous NSCLC
K Thein ... S Swarup
Journal of Thoracic Oncology | VOL. 14
K Thein, et. al.K Thein ... S Swarup
01 Oct 2019
Checkpoint inhibitors in combination with chemotherapy for first-line treatment of advanced squamous non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials (RCTs).
Aung Tun ... James Gasperino
Journal of Clinical Oncology | VOL. 37
Aung Tun, et. al.Aung Tun ... James Gasperino
10 Mar 2019
Checkpoint inhibitors in combination with chemotherapy for first-line treatment of advanced non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials (RCTs).
Wai Lin Thein ... Kyaw Zin Thein
Journal of Clinical Oncology | VOL. 37
Wai Lin Thein, et. al.Wai Lin Thein ... Kyaw Zin Thein
20 May 2019
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Differences in disease characteristics in young vs older adults with colorectal carcinoma.
Shivani Modi ... Adit Dharia
Journal of Clinical Oncology | VOL. 43
Shivani Modi, et. al.Shivani Modi ... Adit Dharia
01 Feb 2025
Sex differences in toxicities and survival outcomes among patients with stage III colorectal cancer receiving adjuvant fluoropyrimidine monotherapy: A pooled analysis of four randomized controlled trials (JCOG2310A).
Hidekazu Hirano ... Yukihide Kanemitsu
Journal of Clinical Oncology | VOL. 43
Hidekazu Hirano, et. al.Hidekazu Hirano ... Yukihide Kanemitsu
01 Feb 2025
Disparities in organ preservation rate for high-risk stage I rectal cancer.
Annmarie Butare ... Michael Honaker
Journal of Clinical Oncology | VOL. 43
Annmarie Butare, et. al.Annmarie Butare ... Michael Honaker
01 Feb 2025
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy in patients with advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) adenocarcinoma enrolled in the Republic of Korea: KEYNOTE-859.
Sun Young Rha ... Do-Youn Oh
Journal of Clinical Oncology | VOL. 43
Sun Young Rha, et. al.Sun Young Rha ... Do-Youn Oh
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.